UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 53

Sortiert nach

CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer

Scientific reports, 2021-10, Vol.11 (1), p.20059-20059, Article 20059

2021

Link zum Volltext

Verfügbarkeit prüfen

Influence of Preoperative Radiation Field on Postoperative Leak Rates in Esophageal Cancer Patients after Trimodality Therapy

Journal of thoracic oncology, 2014-04, Vol.9 (4), p.534-540

2014

Link zum Volltext

Verfügbarkeit prüfen

Definitive Chemoradiation in Locally Advanced Squamous Cell Carcinoma of the Hypopharynx: Long-term Outcomes and Toxicity

Anticancer research, 2018-06, Vol.38 (6), p.3543-3549

2018

Link zum Volltext

Verfügbarkeit prüfen

Comparison of 2 Common Radiation Therapy Techniques for Definitive Treatment of Small Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2013-09, Vol.87 (1), p.139-147

2013

Link zum Volltext

Verfügbarkeit prüfen

Acquired resistance to immunotherapy and chemoradiation in MYC amplified head and neck cancer

NPJ precision oncology, 2024-05, Vol.8 (1), p.114-114

2024

Link zum Volltext

Verfügbarkeit prüfen

Imaging Features of Intratumoral Injection of NBTXR3 for Head and Neck Squamous Cell Carcinoma Lymph Node Metastases

Diagnostics (Basel), 2022-09, Vol.12 (9), p.2156

2022

Link zum Volltext

Verfügbarkeit prüfen

Evolving Paradigm of Radiotherapy for High-Risk Prostate Cancer: Current Consensus and Continuing Controversies

Prostate Cancer, 2016-01, Vol.2016, p.2420786-12

2016

Link zum Volltext

Verfügbarkeit prüfen

Node Out, About It? Consideration of Adjuvant Treatment of Oral Tongue Cancer

International journal of radiation oncology, biology, physics, 2022-03, Vol.112 (4), p.849

2022

Link zum Volltext

Verfügbarkeit prüfen

The oligometastatic spectrum in the era of improved detection and modern systemic therapy

Nature reviews. Clinical oncology, 2022-09, Vol.19 (9), p.585-599

2022

Link zum Volltext

Verfügbarkeit prüfen

A 2D Nanoradiosensitizer Enhances Radiotherapy and Delivers STING Agonists to Potentiate Cancer Immunotherapy

Advanced materials (Weinheim), 2022-09, Vol.34 (39), p.e2110588-n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

Beyond PACIFIC: Uncharted Waters

Journal of thoracic oncology, 2021-05, Vol.16 (5), p.715-718

2021

Link zum Volltext

Verfügbarkeit prüfen

Combined stereotactic body radiotherapy and immune checkpoint inhibition for liver metastases: safety and outcomes in a pooled analysis of three phase I trials

International journal of radiation oncology, biology, physics, 2024-01

2024

Link zum Volltext

Verfügbarkeit prüfen

Two-Dimensional Nanoradiosensitizer Enhances Radiotherapy and Delivers STING Agonists to Potentiate Cancer Immunotherapy

Advanced materials (Weinheim), 2022-08, Vol.34 (39), p.e2110588-e2110588

2022

Link zum Volltext

Verfügbarkeit prüfen

185 Long-Term Results of Induction Chemotherapy Followed by 50 Gy Radiation Therapy Alone for Low-Risk HPV-Positive Oropharynx Cancer

Radiotherapy and oncology, 2024-03, Vol.192, p.S52-S53

2024

Link zum Volltext

Verfügbarkeit prüfen

Phase 1 Randomized Trial of Stereotactic Body Radiation Therapy Followed by Nivolumab plus Ipilimumab or Nivolumab Alone in Advanced/Unresectable Hepatocellular Carcinoma

International journal of radiation oncology, biology, physics, 2023-01, Vol.115 (1), p.202-213

2023

Link zum Volltext

Verfügbarkeit prüfen

The clinical relevance of margins in frameless stereotactic radiosurgery for intact brain metastases: A randomized trial of 0 vs 2 mm margins

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS2080-TPS2080

2023

Link zum Volltext

Verfügbarkeit prüfen

Randomized phase I/II trial of TheraT vectors expressing HPV16 specific antigens with neoadjuvant chemotherapy followed by transoral robotic surgery (TORS) or risk/response stratified chemoradiotherapy (CRT) for locoregional HPV16+ oropharyngeal cancer (OPC)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS6115-TPS6115

2023

Link zum Volltext

Verfügbarkeit prüfen

A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC Study

Journal of thoracic oncology, 2022-01, Vol.17 (1), p.130-140

2022

Link zum Volltext

Verfügbarkeit prüfen

The impact of sequencing PD-1/PD-L1 inhibitors and stereotactic radiosurgery for patients with brain metastasis

Neuro-oncology (Charlottesville, Va.), 2019-08, Vol.21 (8), p.1060-1068

2019

Link zum Volltext

Verfügbarkeit prüfen

Combined Stereotactic Body Radiation Therapy and Immune Checkpoint Inhibition for Liver Metastases: Safety and Outcomes in a Pooled Analysis of 3 Phase 1 Trials

International journal of radiation oncology, biology, physics, 2024-04, Vol.118 (5), p.1519-1530

2024

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant nivolumab, paclitaxel, and carboplatin followed by response-stratified chemoradiation in locoregionally advanced HPV negative head and neck squamous cell carcinoma (HNSCC): The DEPEND trial

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.6007-6007

2023

Link zum Volltext

Verfügbarkeit prüfen

Dares: A phase II trial of durvalumab and ablative radiation in extensive stage small cell lung cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS8615-TPS8615

2023

Link zum Volltext

Verfügbarkeit prüfen

Stereotactic radiosurgery with concurrent lapatinib is associated with improved local control for HER2-positive breast cancer brain metastases

Journal of neurosurgery, 2020-02, Vol.132 (2), p.503-511

2020

Link zum Volltext

Verfügbarkeit prüfen

The risk of radiation necrosis following stereotactic radiosurgery with concurrent systemic therapies

Journal of neuro-oncology, 2017-06, Vol.133 (2), p.357-368

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(46)

Publikationsform

Sprache

Englisch
(53)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(33)
Life Sciences & Biomedicine
(31)
Oncology
(28)
Humans
(27)
Female
(15)
Middle Aged
(15)
Aged
(14)
Male
(13)
Adult
(11)
Retrospective Studies
(11)
Aged, 80 And Over
(10)
Radiation Therapy
(9)
Immunotherapy
(7)
Radiology, Nuclear Medicine & Medical Imaging
(7)
Chemotherapy
(6)
Patients
(6)
Prognosis
(6)
Radiotherapy
(6)
Toxicity
(6)
Follow-Up Studies
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer

Influence of Preoperative Radiation Field on Postoperative Leak Rates in Esophageal Cancer Patients after Trimodality Therapy

Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatment

Definitive Chemoradiation in Locally Advanced Squamous Cell Carcinoma of the Hypopharynx: Long-term Outcomes and Toxicity

Comparison of 2 Common Radiation Therapy Techniques for Definitive Treatment of Small Cell Lung Cancer

Acquired resistance to immunotherapy and chemoradiation in MYC amplified head and neck cancer

Imaging Features of Intratumoral Injection of NBTXR3 for Head and Neck Squamous Cell Carcinoma Lymph Node Metastases

Evolving Paradigm of Radiotherapy for High-Risk Prostate Cancer: Current Consensus and Continuing Controversies

Node Out, About It? Consideration of Adjuvant Treatment of Oral Tongue Cancer

The oligometastatic spectrum in the era of improved detection and modern systemic therapy

A 2D Nanoradiosensitizer Enhances Radiotherapy and Delivers STING Agonists to Potentiate Cancer Immunotherapy

Beyond PACIFIC: Uncharted Waters

Combined stereotactic body radiotherapy and immune checkpoint inhibition for liver metastases: safety and outcomes in a pooled analysis of three phase I trials

Two-Dimensional Nanoradiosensitizer Enhances Radiotherapy and Delivers STING Agonists to Potentiate Cancer Immunotherapy

185 Long-Term Results of Induction Chemotherapy Followed by 50 Gy Radiation Therapy Alone for Low-Risk HPV-Positive Oropharynx Cancer

Phase 1 Randomized Trial of Stereotactic Body Radiation Therapy Followed by Nivolumab plus Ipilimumab or Nivolumab Alone in Advanced/Unresectable Hepatocellular Carcinoma

The clinical relevance of margins in frameless stereotactic radiosurgery for intact brain metastases: A randomized trial of 0 vs 2 mm margins

Randomized phase I/II trial of TheraT vectors expressing HPV16 specific antigens with neoadjuvant chemotherapy followed by transoral robotic surgery (TORS) or risk/response stratified chemoradiotherapy (CRT) for locoregional HPV16+ oropharyngeal cancer (OPC)

A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC Study

The impact of sequencing PD-1/PD-L1 inhibitors and stereotactic radiosurgery for patients with brain metastasis

Combined Stereotactic Body Radiation Therapy and Immune Checkpoint Inhibition for Liver Metastases: Safety and Outcomes in a Pooled Analysis of 3 Phase 1 Trials

Neoadjuvant nivolumab, paclitaxel, and carboplatin followed by response-stratified chemoradiation in locoregionally advanced HPV negative head and neck squamous cell carcinoma (HNSCC): The DEPEND trial

Dares: A phase II trial of durvalumab and ablative radiation in extensive stage small cell lung cancer

Stereotactic radiosurgery with concurrent lapatinib is associated with improved local control for HER2-positive breast cancer brain metastases

The risk of radiation necrosis following stereotactic radiosurgery with concurrent systemic therapies

Suchergebnisse filtern